⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

RGEN

Repligen Corporation

Healthcare · Medical Instruments & Supplies

165.05USD

-3.4800 (-2.06%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 165.05
P/E229.0
Dvd Ind Yld—
P/B4.50
P/S12.1
Curr EV/T12M EBITDA65.5
Mkt Cap (USD)9.5B
Curr EV (USD)9.4B
2)

Per Share Data

EPS T12M0.48
DPS—
Bk Val Per Sh37.43
Rev/Sh13.86
Cash/Sh14.36
Curr Shares Out56.4M
FCF/Sh1.98
3)

Cash Flow Analysis

P/CF70.5
Curr P/FCF84.9
CF/NI3.2
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales17.2%
Eff Interest Rate4.1%
4)

Growth Potential

Dil EPS 1Y Gr287.0%
Cap 1Y Gr6.0%
BPS 1Y Gr5.6%
R&D To Sales7.2%
Retention Rate100.0%
Rev 1Y Gr16.4%
FCF 1Y Gr-37.3%
Assets 1Y Gr4.2%
5)

Profitability

EBITDA0.1B
EBIT0.1B
Operating Margin8.2%
Pretax Margin6.6%
Net Margin5.3%
ROA1.4%
ROE2.0%
ROC1.8%
Asset Turnover0.27
6)

Structure

Current Ratio9.05
Quick Ratio7.30
Debt/Assets23.4%
Debt/Com Eq32.7%
Net Debt/EBITDA0.59
Tot Debt/Capital24.7%
Gross Margin53.8%
EBIT/Int Exp2.9

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.